Cargando…
Development and Validation of Tumor Immunogenicity Based Gene Signature for Skin Cancer Risk Stratification
Melanoma is one of the most aggressive types of skin cancer, with significant heterogeneity in overall survival. Currently, tumor-node-metastasis (TNM) staging is insufficient to provide accurate survival prediction and appropriate treatment decision making for several types of tumors, such as those...
Autores principales: | Yavartanoo, Maryam, Yi, Gwan-Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584987/ https://www.ncbi.nlm.nih.gov/pubmed/34769455 http://dx.doi.org/10.3390/ijms222112025 |
Ejemplares similares
-
Development and validation of a pyroptosis-related genes signature for risk stratification in gliomas
por: Sun, Penggang, et al.
Publicado: (2023) -
Development and Validation of an Autophagy-Stroma-Based Microenvironment Gene Signature for Risk Stratification in Colorectal Cancer
por: Chen, Lin, et al.
Publicado: (2021) -
Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer
por: Liu, Yifan, et al.
Publicado: (2020) -
Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer
por: Qiu, Feng, et al.
Publicado: (2021) -
A novel NHEJ gene signature based model for risk stratification and prognosis prediction in hepatocellular carcinoma
por: Lin, Zhu, et al.
Publicado: (2023)